Unimed Laboratories

Unimed (Union Médicale d'Industrie Pharmaceutique) is a leading pharmaceutical company based in Tunisia, specializing in the development and manufacture of sterile injectable medicines and ophthalmic products. Founded in 1989 and headquartered in Kalaa Kebira, the company has established itself as a regional powerhouse with state-of-the-art manufacturing facilities that comply with European GMP standards. Unimed operates both as a branded generic manufacturer and a strategic contract manufacturing organization (CMO) for global pharmaceutical leaders such as Pfizer, Roche, and Sanofi. The company is particularly noted for its expertise in Blow-Fill-Seal (BFS) technology and lyophilization. Publicly traded on the Tunis Stock Exchange since 2016, Unimed maintains an extensive export network across the Maghreb, Sub-Saharan Africa, and the Middle East.